IL15 and neoplasm: Our data indicated that FAP/IL-15 CAR-T cell treatment significantly suppressed tumor growth and prolonged survival in xenograft-bearing mice compared to FAP CAR-T cells, FAP CAR-T cells combined with exogenous IL-15, and other controls (Fig. 4B, C).